16 unknown. 16 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Unknown 16 |
Follow Bio-innova Co., Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets Sildenafill-Test product, Sildenafill-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 36 | 2025-02-04 | 2024-03-04 |
| Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition Esomeprazole magnesium dihydrate-Test product, Esomeprazole magnesium dihydrate-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 40 | 2024-10-01 | 2024-01-31 |
| Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Dutasteride-Test product, Dutasteride-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 28 | 2024-09-24 | 2024-01-31 |
| Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Vildagliptin and Metformin-Test product, Vildagliptin and Metformin-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 48 | 2024-09-05 | 2024-02-08 |
| Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Febuxostat-Test product, Febuxostat-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 46 | 2024-09-03 | 2024-01-31 |
| Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition Esomeprazole magnesium dihydrate-Test product, Esomeprazole magnesium dihydrate-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 30 | 2024-08-29 | 2024-01-31 |
| Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg Dapagliflozin-Test product, Dapagliflozin-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 30 | 2024-07-23 | 2024-01-31 |
| Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg) Desogestrel-Test product, Desogestrel-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 32 | 2024-07-16 | 2024-01-31 |
| Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg Nebivolol-Test product, Nebivolol-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 46 | 2024-07-09 | 2024-02-08 |
| Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg Ticagrelor-Test product, Ticagrelor-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 36 | 2024-06-18 | 2024-01-31 |
| Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Test product, Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 34 | 2024-06-04 | 2024-01-31 |
| Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets Sacubitril and Valsartan-Test product, Sacubitril and Valsartan-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 40 | 2024-05-06 | 2024-02-08 |
| Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator Sitagliptin and Metformin Hydrochloride Tablets Test product, Sitagliptin and Metformin Hydrochloride Tablets Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 34 | 2024-04-30 | 2024-01-31 |
| Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin® Drospirenone+ Ethinyl Estradiol Tablets-Test product, Drospirenone+ Ethinyl Estradiol Tablets-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 32 | 2024-03-05 | 2024-01-31 |
| Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg Empagliflozin-Test product, Empagliflozin-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 26 | 2024-02-27 | 2024-01-30 |
| Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz® Drospirenone+ Ethinyl Estradiol Tablets-Test product, Drospirenone+ Ethinyl Estradiol Tablets-Reference product - Healthy Subjects | Phase 1 | Unknown | Bio-innova Co., Ltd | 32 | 2024-02-13 | 2024-03-12 |
Metformin (2) · Sitagliptin Phosphate (2) · Vildagliptin (1) · sacubitril (1)
Thailand (1)